20/10/2025, Monday18:13
flag
Yeni Şafak

EDITION   :

TRTRENENARARFRFRRURUURUR

Reklam yükleniyor...

Reklam yükleniyor...

Low youth participation in medical research threatens treatment development

Heba Turkmani
11:53, 20/10/2025, Monday
AA
Low youth participation in medical research threatens treatment development
File photo

Generation Z's significant underrepresentation in clinical trials and medical research may compromise the safety and effectiveness of future treatments for young adults. Experts warn that current recruitment strategies fail to engage young people despite nearly half living with chronic health conditions.

Medical researchers are raising concerns about the dangerously low participation rates of young adults in clinical trials, potentially compromising future treatment development for Generation Z. Despite comprising 8% of England's population, individuals aged 18-24 account for only 4.4% of medical research participants, creating a significant demographic gap in healthcare data that could affect treatment safety and efficacy for this age group.

Health Challenges and Research Disconnect

While young adults experience lower rates of life-threatening conditions like cancer and heart disease, nearly 50% of those under 24 live with chronic physical or mental health conditions requiring appropriate medical interventions. Kirsty Blenkins, deputy head of the Association for Young People's Health, emphasized that this demographic faces unique health challenges shaped by contemporary social pressures and inequalities that current research fails to adequately address.

Consequences of Research Underrepresentation

The participation deficit threatens to create treatments that are less safe or effective for young adults, potentially leading to "poorer health outcomes, delayed diagnosis, and reduced trust or engagement with healthcare systems," according to Blenkins. Data from the National Institute of Health and Care Research reveals that between 2021 and 2024, only 32,879 adults aged 18-24 participated in 5,042 studies—averaging just seven young people per research project.

Barriers to Participation and Demographic Imbalance

Experts identify multiple barriers preventing youth engagement in medical research, including limited awareness, ineffective recruitment strategies, confidentiality concerns, and research protocols not adapted to young adults' needs and lifestyles. This underrepresentation becomes particularly striking when compared to elderly participation—adults aged 85 and over, representing just 2% of the population, accounted for 4.2% of research participants during the same period.

Reklam yükleniyor...

Reklam yükleniyor...

Comments
user

Comments you share on our site are a valuable resource for other users. Please be respectful of different opinions and other users. Avoid using rude, aggressive, derogatory, or discriminatory language.

Page End
Turkey's Accumulation. International Media Group.

Welcome to the news source that sets Turkey's agenda! With its impartial, dynamic, and in-depth journalism, Yeni Şafak offers its readers an experience beyond current events. Get instant updates on what's happening in Turkey and worldwide, with news spanning a wide range from politics and economy to culture, arts, and sports. Access the most accurate information anytime, anywhere with its digital platforms; keep up with the agenda with Yeni Şafak!

Follow us on social media.
Download Mobile Apps

Carry the agenda in your pocket! With Yeni Şafak's mobile apps, get instant access to the latest news. A wide range of content, from politics to economy, sports to culture and arts, is at your fingertips! Easily download it on your iOS, Android, and Huawei devices to quickly access the most accurate information anytime, anywhere. Download now, don't miss out on developments around the world!

Categories
Albayrak Media

Maltepe Mah. Fetih Cad. No:6 34010 Zeytinburnu/İstanbul, Türkiyeiletisim@yenisafak.com+90 212 467 6515

LEGAL DISCLAIMER

The BIST name and logo are protected under a 'Protection Trademark Certificate' and cannot be used, quoted, or modified without permission. All information disclosed under the BIST name is fully copyrighted by BIST and may not be republished. Market data is provided by iDealdata Financial Technologies Inc. BIST stock data is delayed by 15 minutes.

© Net Medya, All right reserved. 2025